Polymorph control: past, present and future.

The appearance and disappearance of polymorphs is no longer a mysterious and inexplicable process. Although methods for polymorph control are still imperfect, there is a large armoury of methods that can be used to tackle this important and challenging problem. We survey the methods and their successes over the last few years.

[1]  S. Velaga,et al.  Supercritical Fluids Crystallization of Budesonide and Flunisolide , 2002, Pharmaceutical Research.

[2]  R. Davey,et al.  Application of Crystallization Inhibitors to Chiral Separations. 1. Design of Additives to Discriminate between the Racemic Compound and the Pure Enantiomer of Mandelic Acid , 2007 .

[3]  Martial Sauceau,et al.  Particle generation for pharmaceutical applications using supercritical fluid technology , 2004 .

[4]  I. Weissbuch,et al.  Crystal Morphology Control with Tailor-Made Additives; A Stereochemical Approach , 2001 .

[5]  P. York,et al.  Polymorph Control of Sulfathiazole in Supercritical CO2 , 2001, Pharmaceutical Research.

[6]  Enrico Drioli,et al.  Influence of the structural properties of poly(vinylidene fluoride) membranes on the heterogeneous nucleation rate of protein crystals. , 2006, The journal of physical chemistry. B.

[7]  Polymorphic Generation through Solvent Selection: Ranitidine Hydrochloride , 2007 .

[8]  Jukka Rantanen,et al.  Crystallization of glycine with ultrasound. , 2006, International journal of pharmaceutics.

[9]  G. Day,et al.  Solvent inclusion in form II carbamazepine. , 2007, Chemical communications.

[10]  Paul E. Shaw,et al.  Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form III. , 2002, Journal of the American Chemical Society.

[11]  Jonathan M Goodman,et al.  Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms. , 2007, Journal of medicinal chemistry.

[12]  M. Takimoto-Kamimura,et al.  Solvent Effect on Polymorphism in Crystallization of BPT Propyl Ester , 2006 .

[13]  Peddy Vishweshwar,et al.  The predictably elusive form II of aspirin. , 2005, Journal of the American Chemical Society.

[14]  Lian Yu.  Color Changes Caused by Conformational Polymorphism: Optical-Crystallography, Single-Crystal Spectroscopy, and Computational Chemistry , 2002 .

[15]  K. Kjaer,et al.  Design and characterization of crystalline thin film architectures at the air-liquid interface: simplicity to complexity. , 2001, Chemical reviews.

[16]  Z. Lepp,et al.  Crystallization of a Desired Metastable Polymorph by Pseudoseeding, Crystal Structure Solution from Its Powder X-ray Diffraction Data, and Confirmation of Polymorphic Transition , 2003 .

[17]  Lance Stewart,et al.  High-throughput crystallization and structure determination in drug discovery. , 2002, Drug discovery today.

[18]  Solubility measurement of polymorphic compounds via the pH-metric titration technique. , 2007, International journal of pharmaceutics.

[19]  I. Weissbuch,et al.  Toward Stereochemical Control, Monitoring, and Understanding of Crystal Nucleation , 2003 .

[20]  K. Järvinen,et al.  Preparation of budesonide/gamma-cyclodextrin complexes in supercritical fluids with a novel SEDS method. , 2006, Journal of pharmaceutical sciences.

[21]  S. Malamataris,et al.  Effects of initial concentration and seeding procedure on crystallisation of orthorhombic paracetamol from ethanolic solution. , 2003, International journal of pharmaceutics.

[22]  S. Chemburkar,et al.  Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development , 2000 .

[23]  B. Shekunov,et al.  Optimisation of powders for pulmonary delivery using supercritical fluid technology. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  J. Bernstein,et al.  3-Aminobenzenesulfonic Acid: A Disappearing Polymorph , 2005 .

[25]  M. Davies,et al.  A comparison of morphology and surface energy characteristics of sulfathiazole polymorphs based upon single particle studies. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  Wolfgang Beckmann,et al.  Seeding the Desired Polymorph: Background, Possibilities, Limitations, and Case Studies , 2000 .

[27]  Zhichao Guo,et al.  Rapid sonocrystallization in the salting-out process , 2003 .

[28]  P. Verwer,et al.  Heterogeneous 2D nucleation of the stable polymorphic form on the metastable form , 2005 .

[29]  H. Tong,et al.  Characterization of Two Polymorphs of Salmeterol Xinafoate Crystallized From Supercritical Fluids , 2001, Pharmaceutical Research.

[30]  James J. P. Stewart,et al.  MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..

[31]  R. Glen,et al.  A new method for the reproducible generation of polymorphs: two forms of sulindac with very different solubilities , 2007 .

[32]  Alfred Y Lee,et al.  Factors Affecting the Polymorphic Outcome of Glycine Crystals Constrained on Patterned Substrates , 2006 .

[33]  Young,et al.  Nonphotochemical, Polarization-Dependent, Laser-Induced Nucleation in Supersaturated Aqueous Urea Solutions. , 1996, Physical review letters.

[34]  San Kiang,et al.  Crystallization Process Development of an Active Pharmaceutical Ingredient and Particle Engineering via the Use of Ultrasonics and Temperature Cycling , 2003 .

[35]  Roger J. Davey,et al.  Polymorph selection: challenges for the future? , 2003 .

[36]  R. Tamura,et al.  Induction and inhibition of preferential enrichment by controlling the mode of the polymorphic transition with seed crystals. , 2006, Chemistry.

[37]  K. Nakajima,et al.  Advances in Crystal Growth Research , 2001 .

[38]  Elias Vlieg,et al.  Toward rational design of Tailor-made additives using growth site statistics , 2007 .

[39]  K. Seddon.  Pseudopolymorph: A Polemic , 2004 .

[40]  B. Shekunov,et al.  Thermal Analysis of Trace Levels of Polymorphic Impurity in Salmeterol Xinafoate Samples , 2003, Pharmaceutical Research.

[41]  R. Davey,et al.  Disappearing polymorphs and the role of reaction by-products: the case of sulphathiazole , 1998 .

[42]  R. Tan,et al.  Molecular Speciation Controlling Stereoselectivity of Additives: Impact on the Habit Modification in α-Glycine Crystals , 2007 .

[43]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[44]  A. Matzger,et al.  The use of polymer heteronuclei for crystalline polymorph selection. , 2002, Journal of the American Chemical Society.

[45]  Enrico Drioli,et al.  A new membrane-based crystallization technique: tests on lysozyme , 2003 .

[46]  Enrico Drioli,et al.  Integrated system for recovery of CaCO3, NaCl and MgSO4·7H2O from nanofiltration retentate , 2004 .

[47]  C. A. Mitchell,et al.  Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates. , 2001, Journal of the American Chemical Society.

[48]  Toshio Oguchi,et al.  Micronization of phenylbutazone by rapid expansion of supercritical CO2 solution. , 2005, Chemical & pharmaceutical bulletin.

[49]  Can crystal structure prediction be used as part of an integrated strategy for ensuring maximum diversity of isolated crystal forms? The case of 2-amino-4-nitrophenol , 2001 .

[50]  Joel Bernstein,et al.  Polymorphism in Molecular Crystals , 2002 .

[51]  Michael J. Cima,et al.  Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. Vlieg,et al.  Epitaxial 2D nucleation of metastable polymorphs: A 2D version of Ostwald's rule of stages , 2005 .

[53]  I. Weissbuch,et al.  Self-Poisoning at {011} Faces of α-Resorcinol Crystals May Explain Its Unidirectional Growth in the Vapor Phase: A Molecular Modeling Study , 2006 .

[54]  G. Whitesides,et al.  Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.

[55]  T. Threlfall.  Crystallisation of Polymorphs: Thermodynamic Insight into the Role of Solvent , 2000 .

[56]  Enrico Drioli,et al.  Trypsin crystallization by membrane-based techniques. , 2005, Journal of structural biology.

[57]  D. Bugay.  Characterization of the solid-state: spectroscopic techniques. , 2001, Advanced drug delivery reviews.

[58]  Ruggero Bettini,et al.  Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[59]  M. Zaworotko,et al.  Concomitant and Conformational Polymorphism, Conformational Isomorphism, and Phase Relationships in 4-Cyanopyridine·4,4‘-biphenol Cocrystals , 2006 .

[60]  G. Desiraju,et al.  On the polymorphism of aspirin: crystalline aspirin as intergrowths of two "polymorphic" domains. , 2007, Angewandte Chemie.

[61]  A. Matzger,et al.  Polymer-induced heteronucleation for the discovery of new extended solids. , 2006, Angewandte Chemie.

[62]  G. P. Stahly.  Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals , 2007 .

[63]  H. Brittain.  Polymorphism in Pharmaceutical Solids , 1999 .

[64]  J. Bernstein.  Cultivating crystal forms. , 2005, Chemical communications.

[65]  W. Beckmann,et al.  Crystallisation of the Stable Polymorph of Hydroxytriendione: Seeding Process and Effects of Purity , 2001 .

[66]  M. Mitchell,et al.  Polymorph and Particle Size Control of PPAR Compounds PF00287586 and AG035029 , 2006 .

[67]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[68]  Harren Jhoti,et al.  High-throughput crystallography for lead discovery in drug design , 2002, Nature Reviews Drug Discovery.

[69]  W. Jiskoot,et al.  Selective Production of Polymorphs and Pseudomorphs Using Supercritical Fluid Crystallization from Aqueous Solutions , 2007 .

[70]  Y. Mastai,et al.  Controlling Polymorphism by Crystallization on Self-Assembled Multilayers , 2007 .

[71]  D. Mastropaolo,et al.  Ranitidine hydrochloride, a polymorphic crystal form. , 2000, Acta crystallographica. Section C, Crystal structure communications.

[72]  Lawrence X. Yu,et al.  Scientific Considerations of Pharmaceutical Solid Polymorphism in Abbreviated New Drug Applications , 2003, Pharmaceutical Research.

[73]  M. Thies,et al.  Effect of material properties and processing conditions on RESS of poly(l-lactide) , 2007 .

[74]  P. Gosselin,et al.  Polymorphic properties of micronized carbamazepine produced by RESS. , 2003, International journal of pharmaceutics.

[75]  L. MacGillivray,et al.  Preparation and reactivity of nanocrystalline cocrystals formed via sonocrystallization. , 2007, Journal of the American Chemical Society.

[76]  R. Hilfiker,et al.  Approaches to Polymorphism Screening , 2006 .

[77]  Naomi E Chayen,et al.  Optimization techniques for automation and high throughput. , 2007, Methods in molecular biology.

[78]  Orn Almarsson,et al.  Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2003, Chemical communications.

[79]  K. Box,et al.  Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases. , 2005, Analytical chemistry.

[80]  A. Nangia.  Pseudopolymorph: retain this widely accepted term , 2006 .

[81]  S. Velaga,et al.  Preparation and characterisation of hydrocortisone particles using a supercritical fluids extraction process. , 2002, International journal of pharmaceutics.

[82]  Da-Peng Wang,et al.  Micronization and microencapsulation of felodipine by supercritical carbon dioxide , 2006, Journal of microencapsulation.

[83]  B Rupp.  Automated High Throughput Drug Target Crystallography , 2005 .

[84]  P. Verwer,et al.  Understanding the Effect of a Solvent on the Crystal Habit , 2004 .

[85]  Jack D. Dunitz,et al.  Crystal and co-crystal: A second opinion , 2003 .

[86]  A. Pandit,et al.  Sonocrystallization: effect on lactose recovery and crystal habit. , 2007, Ultrasonics sonochemistry.

[87]  I. Weissbuch,et al.  Solvent effect on crystal polymorphism: why addition of methanol or ethanol to aqueous solutions induces the precipitation of the least stable beta form of glycine. , 2005, Angewandte Chemie.

[88]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[89]  R. Davey,et al.  Stabilizing a solid–solid interface with a molecular-scale adhesive , 1999, Nature.

[90]  K. Morris,et al.  Stabilization of a Metastable Polymorph of 4-Methyl-2-nitroacetanilide by Isomorphic Additives , 2001 .

[91]  B. Shekunov,et al.  Formation of composite crystals by precipitation in supercritical CO2 , 2003 .

[92]  Enrico Drioli,et al.  Polymeric hydrophobic membranes as a tool to control polymorphism and protein–ligand interactions , 2006 .

[93]  Nils-Olof Lindberg,et al.  Multivariate methods in pharmaceutical applications , 2002 .

[94]  Peter Erk,et al.  The innovative momentum of crystal engineering , 2004 .

[95]  M D Luque de Castro,et al.  Ultrasound-assisted crystallization (sonocrystallization). , 2007, Ultrasonics sonochemistry.

[96]  B. Kaptein,et al.  Dutch resolution of racemates and the roles of solid solution formation and nucleation inhibition. , 2007, Topics in current chemistry.

[97]  P. Günter,et al.  Morphology and Polymorphism Control of Organic Polyene Crystals by Tailor-made Auxiliaries , 2006 .

[98]  Jeffrey S. Tan,et al.  Capillary Precipitation of a Highly Polymorphic Organic Compound , 2003 .

[99]  J. Bernstein,et al.  Serendipity and four polymorphic structures of benzidine, C12H12N2. , 2006, Journal of the American Chemical Society.

[100]  D. Fox.  Physics and Chemistry of the Organic Solid State , 1963 .

[101]  G. Day,et al.  Investigating the latent polymorphism of maleic acid. , 2006, Chemical communications.

[102]  Poovathinthodiyil Raveendran,et al.  Crystallization and processing of carbohydrates using carbon dioxide , 2005 .

[103]  S. Childs,et al.  Polymorph Generation in Capillary Spaces: The Preparation and Structural Analysis of a Metastable Polymorph of Nabumetone , 2002 .

[104]  T. Ishida,et al.  Structure of ranitidine hydrochloride , 1990 .

[105]  R. Docherty,et al.  Polymorphism in Molecular Crystals: Stabilization of a Metastable Form by Conformational Mimicry , 1997 .

[106]  K. Morris,et al.  Influence of Tailor-Made Additives on Etching Patterns of Acetaminophen Single Crystals , 2001, Pharmaceutical Research.

[107]  R. Davey,et al.  Molecular configuration at the solid-solid interface: Twinning in saccharin crystals , 1998 .

[108]  Gordon J. T. Tiddy,et al.  Crystal engineering – nucleation, the key step , 2002 .

[109]  A. Matzger,et al.  Selection and discovery of polymorphs of platinum complexes facilitated by polymer-induced heteronucleation. , 2007, Inorganic chemistry.

[110]  Guangming Li,et al.  Supercritical antisolvent micronization of natural carotene by the SEDS process through prefilming atomization , 2006 .

[111]  A. Myerson,et al.  Supersaturation and Polarization Dependence of Polymorph Control in the Nonphotochemical Laser-Induced Nucleation (NPLIN) of Aqueous Glycine Solutions , 2006 .

[112]  Matthew J. Mollan,et al.  Crystal doping aided by rapid expansion of supercritical solutions , 2002, AAPS PharmSciTech.

[113]  Ruth E. Cameron,et al.  Contact line crystallization to obtain metastable polymorphs , 2007 .

[114]  T. Dupont,et al.  Capillary flow as the cause of ring stains from dried liquid drops , 1997, Nature.

[115]  A. Myerson,et al.  Effect of Additives on the Transformation Behavior of l-Phenylalanine in Aqueous Solution , 2001 .

[116]  R. Chivers,et al.  The microscopic visualisation of the sonocrystallisation of ice using a novel ultrasonic cold stage. , 2004, Ultrasonics sonochemistry.

[117]  B. Shekunov,et al.  Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS). , 2001, Journal of pharmaceutical sciences.

[118]  P. York,et al.  Control of the Physical Form of Salmeterol Xinafoate , 1999 .

[119]  A. Matzger,et al.  Crystalline polymorph selection and discovery with polymer heteronuclei. , 2005, Journal of the American Chemical Society.

[120]  Åke C. Rasmuson,et al.  Influence of Ultrasound on the Nucleation of Polymorphs of p-Aminobenzoic Acid , 2005 .

[121]  In Sung Lee,et al.  Crystallization on confined engineered surfaces: a method to control crystal size and generate different polymorphs. , 2005, Journal of the American Chemical Society.

[122]  T. Sako,et al.  Micronization and Polymorphic Conversion of Tolbutamide and Barbital by Rapid Expansion of Supercritical Solutions , 2006, Drug development and industrial pharmacy.

[123]  C. C. Seaton,et al.  Ordered Aggregation of Benzamide Crystals Induced Using a “Motif Capper” Additive , 2005 .

[124]  Phase transition and heterogeneous/epitaxial nucleation of hydrated and anhydrous theophylline crystals , 1992 .

[125]  P. W. Cains,et al.  Use the power of sonocrystallization for improved properties , 2001 .

[126]  Enrico Drioli,et al.  Selective Glycine Polymorph Crystallization by Using Microporous Membranes , 2007 .

[127]  M. Ward,et al.  Polymorph selectivity under nanoscopic confinement. , 2004, Journal of the American Chemical Society.

[128]  J. Bernstein.  And Another Comment on Pseudopolymorphism , 2005 .

[129]  H. Brittain,et al.  EFFECTS OF PHARMACEUTICAL PROCESSING ON DRUG POLYMORPHS AND SOLVATES , 1999 .

[130]  G. Desiraju.  Counterpoint: what's in a name? , 2004 .